Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance

Dermatology Reports · Published 2026-05-12 · DOI 10.4081/dr.2026.10851

Free full text

Authors (4)

Giovanni Paolino, Matteo Riccardo Di Nicola, Nathalie Rizzo, Santo Raffaele Mercuri

Abstract

Dear Editor, Regression-like dermoscopic and histopathological changes in pre-existing melanocytic nevi have increasingly been reported in patients undergoing modern oncologic therapies, particularly immune checkpoint inhibitors (such as ipilimumab, nivolumab, and pembrolizumab) and targeted agents including BRAF and MEK inhibitors. [...]

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Citation

Paolino, G., Nicola, M., Rizzo, N., et al. (2026). Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance. Dermatology Reports. https://doi.org/10.4081/dr.2026.10851

Related articles